Revumenib Pill Shows Promise Against Leukemia in Early Trial

About a third of patients with relapsed or refractory acute leukemia experienced complete remission after taking the drug, known as revumenib.

Related Keywords

Boston , Massachusetts , United States , Scott Armstrong , Blood Disorders Center , Boston Children , Python Certification Bootcamp , Leukemia , Npm1 , Health , Medical , Dharma , Dancer , Adana , Syndax , Dana Farber Cancer Institute , Acute Lymphoblastic Leukemia , Gene Therapy , Branches Of Biology , Medical Specialties , Dana Farber , Tt , Izmodo ,